{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:26:46Z","timestamp":1791584806599,"version":"4.3.4"},"reference-count":86,"publisher":"Elsevier","isbn-type":[{"value":"9780443345258","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.irn.2026.01.005","type":"book-chapter","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T20:50:54Z","timestamp":1768855854000},"page":"273-298","source":"Crossref","is-referenced-by-count":1,"title":["The potential of HDAC inhibitors for Alzheimer\u2019s disease"],"prefix":"10.1016","author":[{"given":"Vedika","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8751-8491","authenticated-orcid":false,"given":"Sharda","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/bs.irn.2026.01.005_bib1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","volume":"11","year":"2015","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"3","key":"10.1016\/bs.irn.2026.01.005_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","volume":"15","year":"2019","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"1","key":"10.1016\/bs.irn.2026.01.005_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-2012-121009","article-title":"Loss of HDAC5 impairs memory function: Implications for Alzheimer\u2019s disease","volume":"33","author":"Agis-Balboa","year":"2012","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"1","key":"10.1016\/bs.irn.2026.01.005_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1570159X13666151021111609","article-title":"Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration","volume":"14","author":"Ahmad Ganai","year":"2016","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/bs.irn.2026.01.005_bib5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejmech.2019.01.077","article-title":"Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides","volume":"166","author":"Amin","year":"2019","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"6","key":"10.1016\/bs.irn.2026.01.005_bib6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.nut.2009.07.006","article-title":"Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41\/GPR-43 pathways","volume":"26","author":"Aoyama","year":"2010","journal-title":"Nutrition"},{"key":"10.1016\/bs.irn.2026.01.005_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-025-05264-y","article-title":"Histone deacetylase 2 in Alzheimer\u2019s disease: A comprehensive molecular blueprint for therapeutic targeting","author":"Asadi","year":"2025","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/bs.irn.2026.01.005_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/578373","article-title":"Tau phosphorylation by GSK3 in different conditions","volume":"2012","author":"Avila","year":"2012","journal-title":"International Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/bs.irn.2026.01.005_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.brainresbull.2021.12.004","article-title":"Simultaneous administration of bromodomain and histone deacetylase I inhibitors alleviates cognition deficit in Alzheimer\u2019s model of rats","volume":"179","author":"Badrikoohi","year":"2022","journal-title":"Brain Research Bulletin"},{"issue":"9","key":"10.1016\/bs.irn.2026.01.005_bib10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2018.05.005","article-title":"Epigenetic regulation in neurodegenerative diseases","volume":"41","author":"Berson","year":"2018","journal-title":"Trends in Neurosciences"},{"issue":"6","key":"10.1016\/bs.irn.2026.01.005_bib11","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.ejmech.2010.02.030","article-title":"Inside HDAC with HDAC inhibitors","volume":"45","author":"Bertrand","year":"2010","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"12","key":"10.1016\/bs.irn.2026.01.005_bib12","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1111\/bcp.14889","article-title":"Recent developments of HDAC inhibitors: Emerging indications and novel molecules","volume":"87","author":"Bondarev","year":"2021","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"14","key":"10.1016\/bs.irn.2026.01.005_bib13","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1016\/j.bmc.2009.05.042","article-title":"Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies","volume":"17","author":"Bora-Tatar","year":"2009","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/bs.irn.2026.01.005_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00137","article-title":"Histone deacetylase inhibitor alleviates the neurodegenerative phenotypes and histone dysregulation in presenilins-deficient mice","volume":"10","author":"Cao","year":"2018","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/bs.irn.2026.01.005_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137533","article-title":"Histone deacetylase inhibitor attenuates the effects of 27-hydroxycholesterol on the rat brain","volume":"818","author":"Chen","year":"2024","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.irn.2026.01.005_bib16","first-page":"61","author":"Chen","year":"2022","journal-title":"Monitoring HDAC4 Expression in Alzheimer\u2019s Disease Using [18F]TFAHA-PET"},{"key":"10.1016\/bs.irn.2026.01.005_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108700","article-title":"Hydroxamic acid hybrids as histone deacetylase inhibitors for cancer therapy: An update (2022 to date)","volume":"163","author":"Cheng","year":"2025","journal-title":"Bioorganic Chemistry"},{"issue":"11","key":"10.1016\/bs.irn.2026.01.005_bib18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","article-title":"Multiple roles of HDAC inhibition in neurodegenerative conditions","volume":"32","author":"Chuang","year":"2009","journal-title":"Trends in Neurosciences"},{"issue":"7","key":"10.1016\/bs.irn.2026.01.005_bib19","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1039\/D0CC06131J","article-title":"Antibody drug conjugates with hydroxamic acid cargos for histone deacetylase (HDAC) inhibition","volume":"57","author":"Cianferotti","year":"2021","journal-title":"Chemical Communications"},{"key":"10.1016\/bs.irn.2026.01.005_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.pnpbp.2017.11.016","article-title":"PSD95: A synaptic protein implicated in schizophrenia or autism?","volume":"82","author":"Coley","year":"2018","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"13","key":"10.1016\/bs.irn.2026.01.005_bib21","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1177\/1535370220928278","article-title":"Histone deacetylase-3: Friend and foe of the brain","volume":"245","author":"D\u2019Mello","year":"2020","journal-title":"Experimental Biology and Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2026.01.005_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1868-7083-4-5","article-title":"Roles of histone deacetylases in epigenetic regulation: Emerging paradigms from studies with inhibitors","volume":"4","author":"Delcuve","year":"2012","journal-title":"Clinical Epigenetics"},{"issue":"2","key":"10.1016\/bs.irn.2026.01.005_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bmcl.2018.11.034","article-title":"New approaches for the treatment of Alzheimer\u2019s disease","volume":"29","author":"Fish","year":"2019","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/bs.irn.2026.01.005_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/8501693","article-title":"Current research therapeutic strategies for Alzheimer\u2019s disease treatment","volume":"2016","author":"Folch","year":"2016","journal-title":"Neural Plasticity"},{"issue":"10","key":"10.1016\/bs.irn.2026.01.005_bib25","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1177\/0271678X19884742","article-title":"HDAC4 and HDAC5 form a complex with DREAM that epigenetically down-regulates NCX3 gene and its pharmacological inhibition reduces neuronal stroke damage","volume":"40","author":"Formisano","year":"2020","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"issue":"5","key":"10.1016\/bs.irn.2026.01.005_bib26","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.3390\/ijms22052526","article-title":"Knock-Down of HDAC2 in human induced pluripotent stem cell derived neurons improves neuronal mitochondrial dynamics, neuronal maturation and reduces amyloid beta peptides","volume":"22","author":"Frankowski","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"17","key":"10.1016\/bs.irn.2026.01.005_bib27","first-page":"4916","article-title":"FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases","volume":"62","author":"Furumai","year":"2002","journal-title":"Cancer Research"},{"key":"10.1016\/bs.irn.2026.01.005_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/6690523","article-title":"The histone modifications of neuronal plasticity","volume":"2021","author":"Geng","year":"2021","journal-title":"Neural Plasticity"},{"issue":"6","key":"10.1016\/bs.irn.2026.01.005_bib29","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/j.nrleng.2023.05.001","article-title":"Neurodegeneration and epigenetics: A review","volume":"38","author":"Ghosh","year":"2023","journal-title":"Neurolog\u00eda (English Edition)"},{"issue":"3","key":"10.1016\/bs.irn.2026.01.005_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/biology13030157","article-title":"Epigenetic alterations in Alzheimer\u2019s disease: Impact on insulin signaling and advanced drug delivery systems","volume":"13","author":"Greeny","year":"2024","journal-title":"Biology"},{"issue":"19","key":"10.1016\/bs.irn.2026.01.005_bib31","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/bs.irn.2026.01.005_bib32","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1080\/17568919.2025.2533113","article-title":"Epigenetic therapy meets targeted protein degradation: HDAC-PROTACs in cancer treatment","volume":"17","author":"Hussain","year":"2025","journal-title":"Future Medicinal Chemistry"},{"key":"10.1016\/bs.irn.2026.01.005_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103797","article-title":"Design, synthesis and anticancer activity of novel valproic acid conjugates with improved histone deacetylase (HDAC) inhibitory activity","volume":"99","author":"Ibrahim","year":"2020","journal-title":"Bioorganic Chemistry"},{"issue":"28","key":"10.1016\/bs.irn.2026.01.005_bib34","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.2174\/0115680266360664250606110220","article-title":"Histone deacetylase inhibition in Alzheimer\u2019s disease: Molecular mechanisms, therapeutic potential, and future perspectives","volume":"25","author":"Joshi","year":"2025","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"9","key":"10.1016\/bs.irn.2026.01.005_bib35","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1021\/acschemneuro.1c00022","article-title":"Neuroprotective efficacy of co-encapsulated rosiglitazone and vorinostat nanoparticle on streptozotocin induced mice model of Alzheimer disease","volume":"12","author":"K C","year":"2021","journal-title":"ACS Chemical Neuroscience"},{"issue":"6","key":"10.1016\/bs.irn.2026.01.005_bib36","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1083\/jcb.201702187","article-title":"Deacetylation of Miro1 by HDAC6 blocks mitochondrial transport and mediates axon growth inhibition","volume":"218","author":"Kalinski","year":"2019","journal-title":"Journal of Cell Biology"},{"issue":"3","key":"10.1016\/bs.irn.2026.01.005_bib37","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4093\/dmj.2023.0174","article-title":"Roles of histone deacetylase 4 in the inflammatory and metabolic processes","volume":"48","author":"Kang","year":"2024","journal-title":"Diabetes & Metabolism Journal"},{"issue":"1","key":"10.1016\/bs.irn.2026.01.005_bib38","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41467-022-28430-5","article-title":"Schizophrenia-associated SAP97 mutations increase glutamatergic synapse strength in the dentate gyrus and impair contextual episodic memory in rats","volume":"13","author":"Kay","year":"2022","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/bs.irn.2026.01.005_bib39","first-page":"166","article-title":"Histone deacetylase inhibitors: Molecular mechanisms of action and clinical trials as anti-cancer drugs","volume":"3","author":"Kim","year":"2011","journal-title":"American Journal of Translational Research"},{"key":"10.1016\/bs.irn.2026.01.005_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.135749","article-title":"Exercise and pharmacological inhibition of histone deacetylase improves cognitive function accompanied by an increase of gene expressions crucial for neuronal plasticity in the hippocampus","volume":"749","author":"Kitahara","year":"2021","journal-title":"Neuroscience Letters"},{"issue":"3","key":"10.1016\/bs.irn.2026.01.005_bib41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/pathophysiology29030038","article-title":"Critical functions of Histone Deacetylases (HDACs) in modulating inflammation associated with cardiovascular diseases","volume":"29","author":"Kulthinee","year":"2022","journal-title":"Pathophysiology"},{"issue":"1","key":"10.1016\/bs.irn.2026.01.005_bib42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/1570159X19666210609160017","article-title":"Understanding the Role of histone deacetylase and their inhibitors in neurodegenerative disorders: Current targets and future perspective","volume":"20","author":"Kumar","year":"2022","journal-title":"Current Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2026.01.005_bib43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"European Journal of Neurology"},{"issue":"8","key":"10.1016\/bs.irn.2026.01.005_bib44","doi-asserted-by":"crossref","first-page":"9573","DOI":"10.1007\/s12035-025-04866-w","article-title":"HDAC3 as an emerging therapeutic target for Alzheimer\u2019s disease and other neurological disorders","volume":"62","author":"Li","year":"2025","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/bs.irn.2026.01.005_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.129015","article-title":"Zinc-dependent deacetylases (HDACs) as potential targets for treating Alzheimer\u2019s disease","volume":"76","author":"Li","year":"2022","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"1","key":"10.1016\/bs.irn.2026.01.005_bib46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s40001-025-02697-y","article-title":"HDAC4: An emerging target in diabetes mellitus and diabetic complications","volume":"30","author":"Lin","year":"2025","journal-title":"European Journal of Medical Research"},{"issue":"5","key":"10.1016\/bs.irn.2026.01.005_bib47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/13543776.2023.2219393","article-title":"An updated patent review of histone deacetylase (HDAC) inhibitors in cancer (2020 \u2013 present)","volume":"33","author":"Liu","year":"2023","journal-title":"Expert Opinion on Therapeutic Patents"},{"issue":"1","key":"10.1016\/bs.irn.2026.01.005_bib48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/cells10010012","article-title":"HDAC6 in diseases of cognition and of neurons","volume":"10","author":"LoPresti","year":"2020","journal-title":"Cells"},{"key":"10.1016\/bs.irn.2026.01.005_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147191","article-title":"Effects of exercise and pharmacological inhibition of histone deacetylases (HDACs) on epigenetic regulations and gene expressions crucial for neuronal plasticity in the motor cortex","volume":"1751","author":"Maejima","year":"2021","journal-title":"Brain Research"},{"issue":"4","key":"10.1016\/bs.irn.2026.01.005_bib50","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/nan.12518","article-title":"HDAC\u00a02 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer\u2019s disease","volume":"45","author":"Mahady","year":"2019","journal-title":"Neuropathology and Applied Neurobiology"},{"issue":"1","key":"10.1016\/bs.irn.2026.01.005_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202304545","article-title":"Structure\u2010based discovery of a small molecule inhibitor of Histone Deacetylase 6 (HDAC6) that significantly reduces Alzheimer\u2019s disease neuropathology","volume":"11","author":"Mondal","year":"2024","journal-title":"Advanced Science"},{"issue":"3","key":"10.1016\/bs.irn.2026.01.005_bib52","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.3390\/molecules20033898","article-title":"Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents","volume":"20","author":"Mottamal","year":"2015","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/bs.irn.2026.01.005_bib53","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1007\/s00213-018-4975-8","article-title":"Nucleocytoplasmic export of HDAC5 and SIRT2 downregulation: Two epigenetic mechanisms by which antidepressants enhance synaptic plasticity markers","volume":"235","author":"Mu\u00f1oz-Cobo","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2026.01.005_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.782375","article-title":"Histone deacetylase 2 knockdown ameliorates morphological abnormalities of dendritic branches and spines to improve synaptic plasticity in an APP\/PS1 transgenic mouse model","volume":"14","author":"Nakatsuka","year":"2021","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2026.01.005_bib55","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/13872877251314777","article-title":"Brain-penetrant histone deacetylase inhibitor RG2833 improves spatial memory in females of an Alzheimer\u2019s disease rat model","volume":"104","author":"Ndukwe","year":"2025","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"39","key":"10.1016\/bs.irn.2026.01.005_bib56","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.2174\/0929867328666201218123154","article-title":"The hydroxamic acids as potential anticancer and neuroprotective agents","volume":"28","author":"Neganova","year":"2021","journal-title":"Current Medicinal Chemistry"},{"issue":"9","key":"10.1016\/bs.irn.2026.01.005_bib57","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2174\/1389450124666221207090108","article-title":"Histone deacetylase inhibitors as cognitive enhancers and modifiers of mood and behavior","volume":"24","author":"Pal","year":"2023","journal-title":"Current Drug Targets"},{"issue":"2","key":"10.1016\/bs.irn.2026.01.005_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20230137","article-title":"Tau\u2010targeting nanoparticles for treatment of Alzheimer\u2019s disease","volume":"5","author":"Pawar","year":"2025","journal-title":"Exploration"},{"issue":"7","key":"10.1016\/bs.irn.2026.01.005_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104052","article-title":"Restoring the epigenome in Alzheimer\u2019s disease: Advancing HDAC inhibitors as therapeutic agents","volume":"29","author":"Pereira","year":"2024","journal-title":"Drug Discovery Today"},{"issue":"6","key":"10.1016\/bs.irn.2026.01.005_bib60","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.celrep.2017.01.028","article-title":"The role of histone deacetylase 6 in synaptic plasticity and memory","volume":"18","author":"Perry","year":"2017","journal-title":"Cell Reports"},{"key":"10.1016\/bs.irn.2026.01.005_bib61","series-title":"In Natural Product-based Synthetic Drug Molecules in Alzheimer\u2019s Disease","first-page":"427","article-title":"Histone deacetylase inhibitors: Design, synthesis, and biological evaluation","author":"Pulya","year":"2023"},{"issue":"5","key":"10.1016\/bs.irn.2026.01.005_bib62","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1021\/acschemneuro.0c00721","article-title":"PT3: A novel benzamide class histone deacetylase 3 inhibitor improves learning and memory in novel object recognition mouse model","volume":"12","author":"Pulya","year":"2021","journal-title":"ACS Chemical Neuroscience"},{"issue":"23","key":"10.1016\/bs.irn.2026.01.005_bib63","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.3390\/cells13231964","article-title":"JRM-28, a novel HDAC2 inhibitor, upregulates plasticity-associated proteins in hippocampal neurons and enhances morphological plasticity via activation of CREB: Implications for Alzheimer\u2019s disease","volume":"13","author":"Rahman","year":"2024","journal-title":"Cells"},{"issue":"4","key":"10.1016\/bs.irn.2026.01.005_bib64","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PPO.0b013e3182a09e07","article-title":"Histone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinoma","volume":"19","author":"Ramakrishnan","year":"2013","journal-title":"The Cancer Journal"},{"key":"10.1016\/bs.irn.2026.01.005_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108493","article-title":"Class I HDAC inhibition improves object recognition memory consolidation through BDNF\/TrkB pathway in a time-dependent manner","volume":"187","author":"Ramirez-Mejia","year":"2021","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/bs.irn.2026.01.005_bib66","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1007\/s12035-023-03373-0","article-title":"Investigating the synergistic potential of low-dose HDAC3 Inhibition and radiotherapy in Alzheimer\u2019s disease models","volume":"60","author":"Ricciardi","year":"2023","journal-title":"Molecular Neurobiology"},{"issue":"4","key":"10.1016\/bs.irn.2026.01.005_bib67","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/cells10040721","article-title":"GSK-3 and Tau: A key duet in Alzheimer\u2019s Disease","volume":"10","author":"Sayas","year":"2021","journal-title":"Cells"},{"issue":"10284","key":"10.1016\/bs.irn.2026.01.005_bib68","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/bs.irn.2026.01.005_bib69","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/13543776.2019.1708901","article-title":"A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)","volume":"30","author":"Shen","year":"2020","journal-title":"Expert Opinion on Therapeutic Patents"},{"key":"10.1016\/bs.irn.2026.01.005_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1429880","article-title":"Pharmacological HDAC3 inhibition alters memory updating in young and old male mice","volume":"17","author":"Smies","year":"2024","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/bs.irn.2026.01.005_bib71","first-page":"231","author":"Soria Lopez","year":"2019","journal-title":"Alzheimer\u2019s disease"},{"issue":"3","key":"10.1016\/bs.irn.2026.01.005_bib72","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jnr.22227","article-title":"Decreased levels of PSD95 and two associated proteins and increased levels of BCl 2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of A\u03b2","volume":"88","author":"Sultana","year":"2010","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/bs.irn.2026.01.005_bib73","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-025-03995-x","article-title":"Clinical progress and functional modalities of HDAC inhibitor-based combination therapies in cancer treatment","author":"Talom","year":"2025","journal-title":"Clinical and Translational Oncology"},{"key":"10.1016\/bs.irn.2026.01.005_bib74","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.nepig.2014.10.002","article-title":"Histone deacetylases (HDACs) and brain function","volume":"1","author":"Volmar","year":"2015","journal-title":"Neuroepigenetics"},{"issue":"5","key":"10.1016\/bs.irn.2026.01.005_bib75","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1021\/acsanm.2c05272","article-title":"PEGylated polymer\u2013lipid hybrid nanoparticles to enhance in vivo exposure and uptake of repaglinide in brain cells to treat diabetes-linked neurodegenerative disorders","volume":"6","author":"Wadhwa","year":"2023","journal-title":"ACS Applied Nano Materials"},{"issue":"17","key":"10.1016\/bs.irn.2026.01.005_bib76","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1021\/acschemneuro.3c00358","article-title":"Design, synthesis, and proof of concept of balanced dual inhibitors of Butyrylcholinesterase (BChE) and histone deacetylase 6 (HDAC6) for the treatment of Alzheimer\u2019s disease","volume":"14","author":"Wang","year":"2023","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/bs.irn.2026.01.005_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1419685","article-title":"The role of HDAC3 in inflammation: Mechanisms and therapeutic implications","volume":"15","author":"Watson","year":"2024","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.irn.2026.01.005_bib78","series-title":"In Encyclopedia of Molecular Cell Biology and Molecular Medicine","article-title":"Histone modifications","author":"Xhemalce","year":"2011"},{"key":"10.1016\/bs.irn.2026.01.005_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/143269","article-title":"Targeting HDACs: A promising therapy for Alzheimer\u2019s disease","volume":"2011","author":"Xu","year":"2011","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/bs.irn.2026.01.005_bib80","doi-asserted-by":"crossref","DOI":"10.1093\/burnst\/tkad062","article-title":"Histone deacetylase 3-specific inhibitor RGFP966 attenuates oxidative stress and inflammation after traumatic brain injury by activating the Nrf2 pathway","volume":"12","author":"Xu","year":"2024","journal-title":"Burns & Trauma"},{"issue":"1","key":"10.1016\/bs.irn.2026.01.005_bib81","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-017-0089-1","article-title":"The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer\u2019s disease","volume":"6","author":"Yang","year":"2017","journal-title":"Translational Neurodegeneration"},{"key":"10.1016\/bs.irn.2026.01.005_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105724","article-title":"HDAC1\/MAO-B dual inhibitors against Alzheimer\u2019s disease: Design, synthesis and biological evaluation of N-propargylamine-hydroxamic acid\/o-aminobenzamide hybrids","volume":"122","author":"Yao","year":"2022","journal-title":"Bioorganic Chemistry"},{"issue":"1","key":"10.1016\/bs.irn.2026.01.005_bib83","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/JAD-170283","article-title":"Mitochondrial dysfunction triggers synaptic deficits via activation of p38 MAP kinase signaling in differentiated Alzheimer\u2019s disease trans-mitochondrial cybrid cells","volume":"59","author":"Yu","year":"2017","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/bs.irn.2026.01.005_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107410","article-title":"Role of histone deacetylases and their inhibitors in neurological diseases","volume":"208","author":"Zhang","year":"2024","journal-title":"Pharmacological Research"},{"key":"10.1016\/bs.irn.2026.01.005_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fddsv.2025.1662691","article-title":"Advancing histone deacetylase 6 (HDAC6) as a promising therapeutic target for Alzheimer\u2019s disease: from molecular insights to clinical prospects","volume":"5","author":"Zhang","year":"2025","journal-title":"Frontiers in Drug Discovery"},{"issue":"6","key":"10.1016\/bs.irn.2026.01.005_bib86","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41419-021-03880-9","article-title":"Effects of short-chain fatty acids in inhibiting HDAC and activating p38 MAPK are critical for promoting B10 cell generation and function","volume":"12","author":"Zou","year":"2021","journal-title":"Cell Death & Disease"}],"container-title":["International Review of Neurobiology","Brain Energy Metabolism in Alzheimers Disease - Part C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S007477422600005X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S007477422600005X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:19:35Z","timestamp":1785874775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S007477422600005X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443345258"],"references-count":86,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2026.01.005","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}